Feature Updates

Hiro-LS Evolves into Patsnap Eureka LS - The Era of Biopharma AI Agents Begins Now

9 June 2025
3 min read

We are excited to announce a major milestone: Hiro-LS is officially upgrading to Patsnap Eureka LS! This is not just a product update—it’s a game-changing evolution.  

Patsnap Eureka LS marks our transformation from a large language model into an intelligent AI Agent platform, purpose-built for the biopharmaceutical industry. With three specialized AI Agents launching in the first wave, Patsnap Eureka LS is here to help you automate complex workflows, generate domain-specific insights, and elevate human-plus-machine productivity, so you canstay ahead of the curve.

Why Patsnap Eureka LS?

From passive responses to proactive intelligence

Patsnap Eureka LS is designed to understand and execute complex biopharma workflows with scientific literacy and precision. Its agents are scenario-aware, task-driven, and trained specifically for life sciences, helping you cut operational time by 50–90%. 

Meet the core AI agents

1.Pharma Insights Advisor | Your Biopharma Encyclopedia

  • Combines LLM power with premium biopharma data to answer complex queries in under 5 minutes—from drug development to regulatory.
  • Use cases: Rapid intelligence gathering, clinical guidance, competitive landscape and intelligence analysis, arming you to make better decisions, faster. 

2. Pharma Document AnalyzerYour Document Deconstruction Expert

3. Markush Claim DraftingYour AI Chemist for Patent Writing

  • Generates Markush structures based on global chemical data—turning a , three day manual task into a one-click process.
  • Use cases: Patent strategy, scaffold expansion, IP risk forecasting.

4. Antibody-Target PredictorYour Antibody Selection Accelerator

  • Surfaces high-affinity antibody-antigen pairings from massive patent and literature databases, cutting screening time from 2–4 days to just half a day.
  • Use cases: Early-stage antibody discovery, humanization planning, pipeline benchmarking.

5. Pharma CI ExplorerYour Pharma Intelligence Architect

  • Equip you with approved drugs' status insights to tailor your product launch & market entry strategy.
  • Use cases: Market entry strategy optimization, competitive intelligence monitoring, commercial launch preparedness.

These AI agents can be seamlessly integrated into your drug discovery and development workflows today. 

Learn more about Patsnap Eureka LS AI agents. 

Three breakthrough advancements with Patsnap Eureka LS

  • Unmatched Efficiency: Automate workflows to eliminate repetitive tasks.
  • Higher Accuracy: Get insights tailored to life sciences from domain-trained AI
  • Continuous Intelligence: Always learning from new data to keep you ahead.

Experience Patsnap Eureka LS now —where AI Agents become your most capable partners in biopharma innovation.

The Patsnap Eureka LS Team
—Redefining biopharma productivity through AI.

Patent Drafting Pitfalls: Alnylam's Custom Definition Sinks COVID-19 Vaccine Lawsuit
Hot Spotlight
5 min read
Patent Drafting Pitfalls: Alnylam's Custom Definition Sinks COVID-19 Vaccine Lawsuit
6 June 2025
On June 4, 2025, the CAFC issued a precedential decision in a patent infringement case involving mRNA-based COVID-19 vaccines, addressing whether the patentee’s “custom” definition of a term constituted infringement.
Read →
The Radiopharmaceutical Revolution: Transforming Precision Diagnosis to Personalized Therapy
Hot Spotlight
12 min read
The Radiopharmaceutical Revolution: Transforming Precision Diagnosis to Personalized Therapy
9 May 2025
Radiopharmaceuticals, which combine radioactive isotopes with specific molecular carriers, are ushering in a new era of personalized medicine.
Read →
Unlocking the Potential of CLDN18.2: Innovations in Antibody-Drug Conjugates for GI Cancers
Hot Spotlight
12 min read
Unlocking the Potential of CLDN18.2: Innovations in Antibody-Drug Conjugates for GI Cancers
29 April 2025
In 2024, the field of cancer therapeutics has witnessed remarkable progress in targeting Claudin 18.2 (CLDN18.2).
Read →
From Courtrooms to Compliance: Johnson & Johnson’s Fight to Survive the Talc Powder Scandal
Hot Spotlight
20 min read
From Courtrooms to Compliance: Johnson & Johnson’s Fight to Survive the Talc Powder Scandal
28 April 2025
Johnson & Johnson was swept into a mounting legal crisis centered on allegations that its talc-based products caused cancer.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.